Impact of advances in systemic chemotherapy for unresectable pancreatic ductal adenocarcinoma (PDAC) in Alberta, Canada

被引：0
|
作者：
Lee-Ying, R. [1 ]
Loree, J. [2 ]
Cheung, W. Y. [1 ]
Tang, P. [1 ]
机构：
[1] Tom Baker Canc Clin, Med Oncol, Calgary, AB, Canada
[2] British Columbia Canc Agcy, Med Oncol, Vancouver, BC, Canada
来源：
ANNALS OF ONCOLOGY | 2017年 / 28卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
762P
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Clinical outcomes of patients who are frail and elderly with unresectable pancreatic ductal adenocarcinoma (PDAC) treated with chemotherapy
    Wu, Linda
    Berkalieva, Asem
    Silberman, Eric Samuel
    Rudshteyn, Michelle
    Moss, Drew
    Sohval, Sophie
    Hill-Oliva, Michael
    Gandhi, Sonal
    Cohen, Deirdre Jill
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [2] Impact of KRAS alterations in pancreatic ductal adenocarcinoma (PDAC).
    Mehdi, Maahum
    Kamgar, Mandana
    George, Ben
    Szabo, Aniko
    Annunzio, Kaitlin
    Taylor, Bradley W.
    Shreenivas, Aditya Varnam
    Chakrabarti, Sakti
    Thomas, James P.
    Tsai, Susan
    Christians, Kathleen K.
    Evans, Douglas B.
    Clarke, Callisia
    Hall, William Adrian
    Erickson, Beth
    Ahmed, Gulrayz
    Thapa, Bicky
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [3] Impact of intensified chemotherapy in metastatic pancreatic ductal adenocarcinoma (PDAC) in clinical routine in Europe
    Javed, Muhammad Ahsan
    Beyer, Georg
    Le, Nha
    Vinci, Alessio
    Wong, Helen
    Palmer, Daniel
    Morgan, Robert D.
    Lamarca, Angela
    Hubner, Richard A.
    Valle, Juan W.
    Alam, Salma
    Chowdhury, Sumsur
    Ma, Yuk Ting
    Archibugi, Livia
    Capurso, Gabriele
    Maisonneuve, Patrick
    Neesse, Albrecht
    Sund, Malin
    Schober, Marvin
    Krug, Sebastian
    PANCREATOLOGY, 2019, 19 (01) : 97 - 104
  • [4] Targeting Pancreatic Ductal Adenocarcinoma (PDAC)
    Parrasia, Sofia
    Zoratti, Mario
    Szabo, Ildiko
    Biasutto, Lucia
    CELLULAR PHYSIOLOGY AND BIOCHEMISTRY, 2021, 55 (01) : 61 - 90
  • [5] Impact of symptom and functional burden on survival in pancreatic ductal adenocarcinoma (PDAC)
    Pitiyarachchi, O.
    Lin, F. P.
    Spooner, A.
    Sharbeen, G.
    Barker, H. P.
    Thornton, K.
    Collignon, E.
    Ballinger, M. L.
    Thomas, D. M.
    Magenau, A.
    Porazinski, S.
    Raina, A.
    Sjoquist, K. M.
    Chantrill, L. A.
    Gebski, V.
    Sowmya, A.
    Timpson, P.
    Pajic, M.
    Goldstein, D.
    Phillips, P. A.
    ANNALS OF ONCOLOGY, 2024, 35 : S925 - S925
  • [6] Clinical impact of KRAS mutations in metastatic pancreatic ductal adenocarcinoma (PDAC)
    Norton, Carter
    Smith, Jarrod
    Rubnitz, Zach
    Tan, Grace H.
    Nevala-Plagemann, Christopher Duane
    Soares, Heloisa P.
    Garrido-Laguna, Ignacio
    Florou, Vaia
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (3_SUPPL) : 619 - 619
  • [7] Clinical impact of visceral thrombosis (VT) in pancreatic ductal adenocarcinoma (PDAC).
    Hicks, Angel Mier
    Raj, Micheal
    Do, Richard Kinh Gian
    Yu, Kenneth H.
    Lowery, Maeve Aine
    Varghese, Anna M.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (04)
  • [8] Impact of age on genomic alterations associated with pancreatic ductal adenocarcinoma (PDAC).
    George, Ben
    Bailey, Mark
    Schrock, Alexa Betzig
    Thorpe, Lauren
    Gay, Laurie M.
    Ritch, Paul S.
    Thomas, James P.
    Erickson, Beth
    Tsai, Susan
    Christians, Kathleen K.
    Evans, Douglas B.
    Stephens, Philip J.
    Miller, Vincent A.
    Ross, Jeffrey S.
    Singhi, Aatur D.
    Ali, Siraj Mahamed
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (04)
  • [9] Evaluation of systemic inflammatory response (SIR) markers in pancreatic ductal adenocarcinoma (PDAC)
    Markus, M.
    Kasper, S.
    Noureddine, R.
    Abramczyk, M.
    Paul, A.
    Gerken, G.
    Schmid, K. W.
    Markus, P.
    Schumacher, B.
    Meiler, J.
    Wiesweg, M.
    Kaiser, G.
    Dechene, A.
    Trarbach, T.
    Schuler, M.
    Abendroth, A.
    Oncology Research and Treatment, 2015, 38 : 4 - 5
  • [10] Overexpression of Mesothelin in Pancreatic Ductal Adenocarcinoma (PDAC)
    Le, Kai
    Wang, Jia
    Zhang, Tao
    Guo, Yifan
    Chang, Hong
    Wang, Siyuan
    Zhu, Bin
    INTERNATIONAL JOURNAL OF MEDICAL SCIENCES, 2020, 17 (04): : 422 - 427
12345